X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (163) 163
oncology (144) 144
index medicus (143) 143
female (104) 104
male (102) 102
middle aged (91) 91
aged (88) 88
lung neoplasms - genetics (80) 80
article (77) 77
lung neoplasms - drug therapy (74) 74
mutation (71) 71
adult (68) 68
gefitinib (60) 60
aged, 80 and over (59) 59
lung neoplasms - pathology (53) 53
lung cancer (49) 49
adenocarcinoma - genetics (48) 48
carcinoma, non-small-cell lung - drug therapy (48) 48
respiratory system (46) 46
cancer (43) 43
chemotherapy (43) 43
erlotinib (43) 43
carcinoma, non-small-cell lung - genetics (40) 40
receptor, epidermal growth factor - genetics (39) 39
treatment outcome (37) 37
egfr (34) 34
neoplasm staging (34) 34
tumors (34) 34
antineoplastic agents - therapeutic use (32) 32
adenocarcinoma (30) 30
prognosis (30) 30
protein kinase inhibitors - therapeutic use (30) 30
proto-oncogene proteins - genetics (28) 28
carcinoma, non-small-cell lung - pathology (27) 27
erlotinib hydrochloride (27) 27
ras proteins - genetics (27) 27
adenocarcinoma - drug therapy (26) 26
gene-mutations (26) 26
lung neoplasms - mortality (26) 26
proto-oncogene proteins p21 (25) 25
acquired-resistance (24) 24
adenocarcinoma - pathology (23) 23
care and treatment (22) 22
erbb receptors - genetics (22) 22
open-label (22) 22
drug resistance, neoplasm (21) 21
therapy (21) 21
adenocarcinoma of lung (20) 20
drug resistance, neoplasm - genetics (20) 20
growth-factor receptor (20) 20
hematology, oncology and palliative medicine (20) 20
lung cancer, non-small cell (19) 19
retrospective studies (19) 19
kras (18) 18
lung neoplasms - diagnosis (18) 18
metastasis (18) 18
non-small cell lung cancer (18) 18
receptor, epidermal growth factor - antagonists & inhibitors (18) 18
research (18) 18
survival rate (18) 18
abridged index medicus (17) 17
adenocarcinomas (17) 17
growth-factor-receptor (17) 17
mutations (17) 17
quinazolines - therapeutic use (17) 17
antineoplastic combined chemotherapy protocols - therapeutic use (16) 16
cell lung-cancer (16) 16
pathology (16) 16
carcinoma, non-small-cell lung - mortality (15) 15
egfr mutations (15) 15
pulmonary and respiratory medicine (15) 15
resistance (15) 15
survival (15) 15
tyrosine kinase inhibitors (15) 15
crizotinib (14) 14
disease-free survival (14) 14
gene rearrangement (14) 14
patients (14) 14
respiratory tract diseases (14) 14
anaplastic lymphoma kinase (13) 13
clinical trials as topic (13) 13
epidermal growth factor receptor (13) 13
genetic testing (13) 13
lung adenocarcinoma (13) 13
receptor protein-tyrosine kinases - genetics (13) 13
surgery (13) 13
t790m mutations (13) 13
cancer therapies (12) 12
dna mutational analysis (12) 12
kinases (12) 12
phase-ii trial (12) 12
quinazolines - administration & dosage (12) 12
recurrence (12) 12
sensitivity (12) 12
survival analysis (12) 12
thymoma (12) 12
disease progression (11) 11
human necessities (11) 11
hygiene (11) 11
inhibitor (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 06/2018, Volume 124, Issue 11, pp. 2272 - 2275
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2013, Volume 31, Issue 8, pp. 992 - 1001
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2017, Volume 35, Issue 30, pp. 3484 - 3515
Journal Article
by Zehir, Ahmet and Benayed, Ryma and Shah, Ronak H and Syed, Aijazuddin and Middha, Sumit and Kim, Hyunjae R and Srinivasan, Preethi and Gao, Jianjiong and Chakravarty, Debyani and Devlin, Sean M and Hellmann, Matthew D and Barron, David A and Schram, Alison M and Hameed, Meera and Dogan, Snjezana and Ross, Dara S and Hechtman, Jaclyn F and DeLair, Deborah F and Yao, JinJuan and Mandelker, Diana L and Cheng, Donavan T and Chandramohan, Raghu and Mohanty, Abhinita S and Ptashkin, Ryan N and Jayakumaran, Gowtham and Prasad, Meera and Syed, Mustafa H and Rema, Anoop Balakrishnan and Liu, Zhen Y and Nafa, Khedoudja and Borsu, Laetitia and Sadowska, Justyna and Casanova, Jacklyn and Bacares, Ruben and Kiecka, Iwona J and Razumova, Anna and Son, Julie B and Stewart, Lisa and Baldi, Tessara and Mullaney, Kerry A and Al-Ahmadie, Hikmat and Vakiani, Efsevia and Abeshouse, Adam A and Penson, Alexander V and Jonsson, Philip and Camacho, Niedzica and Chang, Matthew T and Won, Helen H and Gross, Benjamin E and Kundra, Ritika and Heins, Zachary J and Chen, Hsiao-Wei and Phillips, Sarah and Zhang, Hongxin and Wang, Jiaojiao and Ochoa, Angelica and Wills, Jonathan and Eubank, Michael and Thomas, Stacy B and Gardos, Stuart M and Reales, Dalicia N and Galle, Jesse and Durany, Robert and Cambria, Roy and Abida, Wassim and Cercek, Andrea and Feldman, Darren R and Gounder, Mrinal M and Hakimi, A. Ari and Harding, James J and Iyer, Gopa and Janjigian, Yelena Y and Jordan, Emmet J and Kelly, Ciara M and Lowery, Maeve A and Morris, Luc G. T and Omuro, Antonio M and Raj, Nitya and Razavi, Pedram and Shoushtari, Alexander N and Shukla, Neerav and Soumerai, Tara E and Varghese, Anna M and Yaeger, Rona and Coleman, Jonathan and Bochner, Bernard and Riely, Gregory J and Saltz, Leonard B and Scher, Howard I and Sabbatini, Paul J and Robson, Mark E and Klimstra, David S and Taylor, Barry S and Baselga, Jose and Schultz, Nikolaus and Hyman, David M and Arcila, Maria E and Solit, David B and Ladanyi, Marc and Berger, Michael F
Nature Medicine, ISSN 1078-8956, 06/2017, Volume 23, Issue 6, pp. 703 - 713
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 01/2016, Volume 14, Issue 1, pp. 44 - 45
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 4, pp. 452 - 463
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2014, Volume 371, Issue 21, pp. 1963 - 1971
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 2, pp. 234 - 242
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2013, Volume 368, Issue 25, pp. 2385 - 2394
In a prospective, randomized, phase 3 trial of crizotinib as second-line therapy in patients who had disease progression while receiving a platinum-based... 
REARRANGEMENT | MEDICINE, GENERAL & INTERNAL | GEFITINIB | ONCOLOGY | EML4-ALK FUSION GENE | CLINICAL-TRIALS | PHASE-III | LYMPHOMA | OPEN-LABEL | DOCETAXEL | EGFR | Glutamates - therapeutic use | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Glutamates - adverse effects | Guanine - analogs & derivatives | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Young Adult | Taxoids - therapeutic use | Pyridines - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Guanine - adverse effects | Guanine - therapeutic use | Taxoids - adverse effects | Pyrazoles - adverse effects | Pyridines - therapeutic use | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Pemetrexed | Disease-Free Survival | Protein Kinase Inhibitors - therapeutic use | Quality of Life | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Tyrosine | Intravenous administration | Biomedical research | Lung cancer | Liver | Fatigue | Chromosome rearrangements | Cancer therapies | Patients | Lymphoma | Metastases | Ovarian cancer | Quality of life | Confidence intervals | Chemotherapy | Dyspnea | Alopecia | Platinum | Lymphomas | Respiration | Pharmaceutical industry | Protein-tyrosine kinase
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 11, pp. 1004 - 1012
Journal Article